Hims & Hers Health Investors Affected by Securities Fraud Lawsuit

Hims & Hers Health, Inc. investors who lost money have an opportunity to lead a securities fraud class action lawsuit. The complaint alleges that the company failed to disclose the deceptive promotion of knockoff versions of Wegovy and the risk of termination of its collaboration with Novo Nordisk. Investors with losses may lead the lawsuit by contacting The Law Offices of Frank R. Cruz before August 25, 2025.

Investors who lost money in Hims & Hers Health, Inc. (HIMS) have an opportunity to lead a securities fraud class action lawsuit. The complaint alleges that the company failed to disclose the deceptive promotion of knockoff versions of Wegovy and the risk of termination of its collaboration with Novo Nordisk. Investors with losses may lead the lawsuit by contacting The Law Offices of Frank R. Cruz before August 25, 2025.

The lawsuit, filed by the Law Offices of Howard G. Smith, alleges that between April 29, 2025, and June 23, 2025, the company made materially false and/or misleading statements and failed to disclose material adverse facts about its business, operations, and prospects. Specifically, the complaint alleges that Hims engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk." It also alleges that the company failed to disclose the substantial risk that its collaboration with Novo Nordisk would be terminated due to these practices [2].

The lawsuit further alleges that the company's positive statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis. This led to a significant decline in the company's stock price on June 23, 2025, when Novo Nordisk announced it was ending its partnership with Hims [3].

Investors who suffered losses in Hims & Hers Health, Inc. are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights. The firm represents investors in securities fraud class actions on a contingency fee basis, meaning there is no cost to investors unless the firm is successful in recovering damages. The deadline to request that the court appoint you as lead plaintiff is August 25, 2025 [2].

References:
[1] https://www.morningstar.com/news/pr-newswire/20250815ph52704/hims-hers-health-inc-hims-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit
[2] https://www.morningstar.com/news/globe-newswire/9513018/hims-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-hims-hers-health-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit
[3] https://www.morningstar.com/news/globe-newswire/9515041/hims-investors-have-the-opportunity-to-lead-the-hims-hers-health-securities-fraud-lawsuit-with-faruqi-faruqi-llp